City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs
- U.S. IPO 近 90 天出现 6 次
- 上一次：同一天稍早 · TRex Bio raised $116.7 million in a U.S. IPO, pricing at the bottom of its range
发生了什么
The Cambridge, Massachusetts company is offering 9.72 million shares at $17 to $19 each and plans to list on Nasdaq under the symbol CTY
摘要按规则整理自下方来源原文